Head & Neck/Thyroid Cancers
From the Journals
Chronic stress, especially race related, may hasten cancer death
High allostatic load was associated with an 80% increased risk of cancer death among all study participants.
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
Feature
Glioblastoma spreading strategies discovered
The more-or-less specific interaction between the nerve cells and the tumor cells also offers starting points for therapies, from our point of...
From the Journals
Novel co-admin of CAR T cells achieves 99% remission in leukemia
“We do believe [this approach] will become standard of care.”
Conference Coverage
ctDNA hints at esophageal cancer outcomes
Reductions in ctDNA were associated with better progression-free and overall survival.
Latest News
New EU guidelines: Individualize care for thyroid cancer in kids
Pediatric differentiated thyroid carcinoma “is not adult DTC in a small person; it has different genetics and a different clinical behavior.”
From the Journals
Safe to expand limits of active surveillance in thyroid cancer?
Raising the limits for tumor size and growth showed no increase in adverse outcomes or mortality.
Latest News
Children with low-risk thyroid cancer can skip radioactive iodine
Withholding RAI therapy is clinically beneficial as it reduces exposure to radiation while having no negative effect on remission.
From the Journals
Analysis suggests an ‘urgent need’ for personalized head and neck cancer follow-up
Assessment schedules should be individualized and evidence-based to assess cancer recurrence.
From the Journals
When cisplatin won’t do, try carboplatin in head and neck cancer
A retrospective analysis suggests carboplatin is better than cetuximab as a radiosensitizing agent.
From the Journals
Is early-onset cancer an emerging global epidemic?
“This paper ... brings to light the importance of correctable lifestyle habits that may slow the rise of early onset cancers.”